Trial Profile
PHASE I-II STUDY OF GEMCITABINE (GCB) AND VALPROIC ACID(VPA) PLUS VALGANCICLOVIR(GCV) IN PATIENTS WITH ADVANCED NASOPHARYNGEAL CARCINOMA(NPC).
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Valganciclovir (Primary) ; Valproic acid (Primary)
- Indications Nasopharyngeal cancer
- Focus Adverse reactions; Pharmacogenomic
- 16 Feb 2011 New trial record